Stocktoria
CARLSMED, INC. CARL
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-07-23
Chart by TradingView
5/9
Piotroski F — financial health
4.88
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| Financials | ||
| Revenue | $50.5M | $27.2M |
| Gross profit | $38.0M | $20.0M |
| Operating income | -$30.6M | -$24.1M |
| Net income | -$29.6M | -$24.3M |
| Operating cash flow | -$29.0M | -$25.5M |
| Free cash flow | -$29.6M | -$25.6M |
| Total assets | $130.1M | $51.8M |
| Total liabilities | $31.3M | $26.2M |
| Shareholders' equity | $98.9M | -$70.6M |
| Ratios | ||
| Gross margin | 75.3% | 73.8% |
| Operating margin | -60.5% | -88.8% |
| Net margin | -58.7% | -89.3% |
| FCF margin | -58.6% | -94.4% |
| Return on assets | -22.8% | -46.8% |
| Return on equity | -30.0% | 34.3% |
| Debt / equity | 0.16× | -0.22× |
| Current ratio | 8.87 | 5.60 |
| Revenue growth | 85.9% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 10,400 | $94,120 |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 4.88 (safe)
- Working capital / assets 0.864
- Retained earnings / assets -0.775
- EBIT / assets -0.235
- Equity / liabilities 3.164
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001794546 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.